Disorder Clinical Trials

4,431 recruitingLast updated: May 13, 2026

There are 4,431 actively recruiting disorder clinical trials across 93 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Disorder Trials at a Glance

4,431 actively recruiting trials for disorder are listed on ClinicalTrialsFinder across 6 cities in 93 countries. The largest study group is Not Applicable with 2,335 trials, with the heaviest enrollment activity in Boston, New York, and Houston. Lead sponsors running disorder studies include Yale University, VA Office of Research and Development, and Stanford University.

Treatments under study

About Disorder Clinical Trials

Looking for clinical trials for Disorder? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 4,431 trials

Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Bipolar 1 Disorder
Rapport Therapeutics Inc.250 enrolled22 locationsNCT07046494
Recruiting
Phase 3

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

DepressionBipolar I Disorder
AbbVie380 enrolled81 locationsNCT04777357
Recruiting
Not Applicable

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

HIV InfectionsHIV InfectionAlcohol Use Disorder+2 more
San Diego State University716 enrolled1 locationNCT06771843
Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

StrokeBrain DiseaseVascular Diseases+1 more
National Institute of Neurological Disorders and Stroke (NINDS)450 enrolled1 locationNCT06615973
Recruiting
Phase 1

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

Obsessive-Compulsive Disorder
Francisco A Moreno30 enrolled1 locationNCT07347405
Recruiting
Not Applicable

The Ailliance Post-Market Clinical Study

Spinal DeformitySpinal Degenerative DisorderSpinal Fusion Failure+2 more
Medtronic Spinal and Biologics1,000 enrolled26 locationsNCT05856370
Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

AlcoholismSubstance-Related Disorders
National Institute on Drug Abuse (NIDA)10,000 enrolled1 locationNCT06676059
Recruiting

Auditory Functions in Patients With Multiple Sclerosis

Multiple SclerosisHearing Disorders
University of Catania30 enrolled1 locationNCT06164483
Recruiting
Not Applicable

Treatment of Complex Post-traumatic Stress Disorder Among Displaced People in Switzerland and Germany

Complex Post-Traumatic Stress Disorder
Eva Heim288 enrolled7 locationsNCT07015567
Recruiting
Phase 1

Environment and Alcohol: A Pilot Study

Alcohol Use Disorder
National Institute on Drug Abuse (NIDA)44 enrolled1 locationNCT06860607
Recruiting

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Bleeding DisorderHeavy Menstrual Bleeding
University Hospital, Geneva163 enrolled1 locationNCT06740929
Recruiting
Not Applicable

Accelerated High-Dose tDCS for Depression

Major DepressionMajor Depression Disorders
Medical University of South Carolina20 enrolled1 locationNCT07226011
Recruiting
Phase 3

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled172 locationsNCT06929273
Recruiting
Phase 3

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Major Depressive Disorder
Neumora Therapeutics, Inc.1,000 enrolled178 locationsNCT06029439
Recruiting
Not Applicable

Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients

Postoperative Neurocognitive DisorderInsomniaPostoperative Delirium+1 more
Massachusetts General Hospital50 enrolled1 locationNCT06375265
Recruiting
Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Major Depressive DisorderAnxiety Disorders
National Institute of Mental Health (NIMH)3,500 enrolled2 locationsNCT00018057
Recruiting

Inherited Reproductive Disorders

InfertilityHypogonadismAmenorrhea+1 more
National Institute of Environmental Health Sciences (NIEHS)850 enrolled2 locationsNCT01500447
Recruiting

A Natural History Study of Metabolic Sizing in Health and Disease

CancerDiabetesChronic Kidney Disease+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,000 enrolled1 locationNCT05398783
Recruiting
Not Applicable

TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

AutismAutism Spectrum DisorderPTSD and Trauma-related Symptoms+2 more
Dartmouth-Hitchcock Medical Center24 enrolled1 locationNCT07420478
Recruiting
Phase 1

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI)75 enrolled1 locationNCT06090669